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Cerebral autoregulation in different
hypertensive disorders of pregnancy
Teelkien R. van Veen, MD; Ronney B. Panerai, PhD; Sina Haeri, MD; Jasbir Singh, MD;
Jasvant A. Adusumalli, MD; Gerda G. Zeeman, MD, PhD; Michael A. Belfort, MD, PhD
OBJECTIVE: Cerebrovascular complications that are associated with RESULTS: ARI was significantly reduced in preeclampsia (ARI, 5.5
hypertensive disorders of pregnancy (preeclampsia, chronic hyper-
tension [CHTN], and gestational hypertension [GHTN]) are believed to
be associated with impaired cerebral autoregulation, which is a
physiologic process that maintains blood flow at an appropriate level
despite changes in blood pressure. The nature of autoregulation
dysfunction in these conditions is unclear. We therefore evaluated
autoregulation in 30 patients with preeclampsia, 30 patients with
CHTN, and 20 patients with GHTN and compared them with a control
group of 30 normal pregnant women.
STUDY DESIGN: The autoregulatory index (ARI) was calculated with the
use of simultaneously recorded cerebral blood flow velocity in the
middle cerebral artery (transcranial Doppler ultrasound), blood pres-
sure (noninvasive arterial volume clamping), and end-tidal carbon
dioxide during a 7-minute period of rest. ARI values of 0 and 9 indicate
absent and perfect autoregulation, respectively. We use analysis of
variance with Bonferroni test vs a control group. Data are presented as
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not in GHTN (ARI, 6.7  0.8; P ¼ 1.0) when compared with
control subjects (ARI, 6.7  0.8). ARI was more decreased in
patients with CHTN who subsequently experienced preeclampsia
than in those who did not (ARI, 3.9  1.9 vs 6.1  1.2; P ¼
.001). This was not true for women with GHTN or control subjects
who later experienced preeclampsia.
CONCLUSION: Pregnant women with CHTN or preeclampsia (even
after exclusion of superimposed preeclampsia) have impaired
autoregulation when compared with women with GHTN or
normal pregnancy. Whether the decreased ARI in patients with
CHTN who later experience preeclampsia is due to preexistent
differences or early affected cerebral circulation remains to be
determined.
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2015;212:513.e1-7.ypertension is one of the mostH common medical complications
of pregnancy, accounting for 16-38% of
all maternal deaths.1,2 Althoughmultiple
maternal organs can be affected, cere-
brovascular involvement is one of the
more serious because it can lead to death
or long-term morbidity because of ce-
rebrovascular hemorrhage or edema.1,2
The cerebral manifestations in thesepatients are similar to those that are seen
in the posterior reversible encephalopa-
thy syndrome,3,4 which is hypothesized
to be related to impaired autoregulation
and which leads to either over- or
underperfusion of the brain.3,5,6
Hypertensive disorders of pregnancy
range in a spectrum from chronic hy-
pertension (CHTN) to gestational hy-
pertension (GHTN), preeclampsia, andr Groningen, University
artment of Obstetrics
and Belfort), and St.
stin (Drs Haeri, Singh,
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APRIL 2015 Amerisuper-imposed preeclampsia (SiPE) in
the setting of CHTN. Women with
CHTN have an increased risk of the
development of SiPE. The incidence has
been reported to be from 12-29%,7-9
although women with severe CHTN in
the ﬁrst trimester have been reported to
go on to SiPE in up to 52% of cases.10
The risk for cerebrovascular complica-
tions during pregnancy is increased with
all hypertensive disorders11-13 but is
most pronounced with severe pre-
eclampsia and SiPE.12,13 These compli-
cations are believed to be caused by
impaired cerebral autoregulation, which
is related to endothelial dysfunction.14
Cerebral autoregulation is the ability
of the cerebral vasculature to maintain
adequate cerebral perfusion despite
changes in blood pressure. The cerebral
autoregulation can be assessed by the use
of a combination of transcranial Doppler
(TCD) imaging and continuous nonin-
vasive blood pressure measurement.15can Journal of Obstetrics& Gynecology 513.e1
Research Obstetrics ajog.orgThe functionality of the autoregulation
can be expressed as the autoregulatory
index (ARI), with 0 being absent and 9
perfect cerebral autoregulation.16 This
ARI has been shown to be lower in pre-
eclampsia when compared with
normotensive control subjects.5 The ARI
was independent of blood pressure and
clinical symptoms, which may explain
the reason that cerebral complications
such as eclampsia and cerebrovascular
hemorrhage can occur without sudden
and/or excessive elevation in blood
pressure.5 The ARI of the other hyper-
tensive disorders in pregnancy is not
known. Based on the increased risks of
cerebrovascular complications that are
seen in pregnancies that are complicated
by CHTN and preeclampsia, but not in
GHTN, we hypothesize that the autor-
egulation is impaired in CHTN (as has
been shown for preeclampsia), but not
in GHTN.
Consequently, the aim of this study
was to evaluate cerebral autoregulation
in hypertensive disorders of pregnancy
(SiPE, preeclampsia, CHTN, and
GHTN) and to compare this with a
control group of normal pregnant
women. Furthermore, we measured the
more traditional parameters of cerebral
blood ﬂow velocity (CBFV), critical
closing pressure (CrCP), and resistance-
area-product to gain additional insight
in the pathophysiologic condition.
MATERIALS AND METHODS
We conducted a prospective cohort
study in nonlaboring pregnant women
who were recruited at 20-41 weeks’
gestation. The Institutional Review
Boards at Baylor College of Medicine in
Houston, TX, and North Austin Medical
Center in Austin, TX, approved this
study; informed consent was obtained
from each participant before data
collection.
Patients were recruited and tested at
Texas Children’s Pavilion for Women in
Houston and North Austin Maternal-
Fetal Medicine in Austin, TX, either at
the time of admission to the hospital for
treatment of a hypertensive disorder or
at the time of routine prenatal care. In-
clusion criteria were maternal age >18
years and absence of a history of513.e2 American Journal of Obstetrics& Gynecolcerebrovascular disease or epilepsy. Hy-
pertensive diagnoses were based on
American College of Obstetricians and
Gynecologists guidelines.17,18 Exclusion
criteria consisted of smoking, drug use,
and the initiation of antihypertensive
therapy or treatment with magnesium
sulfate <48 hours before the
examination.
With the use of a standard data
collection sheet, demographic charac-
teristics and obstetrics data were
abstracted from patient interviews and
medical records. The following maternal
characteristics were based on self-report:
race/ethnicity, height, current and pre-
pregnancy weight, smoking, alcohol,
and illicit substance use. Gestational age
was determined by menstrual dating. In
cases of uncertain menstrual dates, ul-
trasound estimates of gestational age
were used. Patients were followed until 6
weeks after delivery.
At time of TCD examination, brachial
systolic and diastolic blood pressures
were measured. With the patients in
semi-Fowlers position, bilateral
maternal TCD examinations of the
middle cerebral artery were carried out
with the use of 2-MHz pulsed, range-
gated TCD probes (Spencer Technolo-
gies, Seattle, WA) that were held in place
with the use of a head frame.
Blood pressure was measured
continuously noninvasively with ﬁnger
arterial volume clamping (Finometer
Pro; Finapres Medical Systems, Amster-
dam, the Netherlands) with the servo-
adjust switched off and was afterwards
calibrated with the brachial blood pres-
sure. The blood pressure tracing also
served to mark each cardiac cycle. End-
tidal CO2 was measured with a nasal
cannula (Nellcor Oximax N-85; Covi-
dien, Mansﬁeld, MA), and linearly
interpolated at the end of each expira-
tory phase.
Patients were measured only once for
a period of 7 minutes. All data were
recorded at 50 Hz, interpolated to 200
Hz, and visually inspected during anal-
ysis to remove large spikes. A median
ﬁlter was used to remove small spikes
and artifacts in the CBFV signal. All
signals were then low-pass ﬁltered with
a Butterworth ﬁlter with a cutoffogy APRIL 2015frequency of 20 Hz.19 Mean blood
pressure, bilateral CBFV, end-tidal CO2,
and heart rate were then calculated for
each beat. The CrCP and resistance-area
product (RAP) were obtained with the
use of the ﬁrst harmonic of blood pres-
sure and CBFV of each cardiac cycle.20
All signals were then resampled at
5 Hz.19
Cerebral autoregulation was deter-
mined from the CBFV responses to
spontaneous ﬂuctuations in mean arte-
rial blood pressure, as described previ-
ously.19 Segments of 512 samples and
50% superposition were transformed
with the fast Fourier transform algo-
rithm, with the use of theWelchmethod,
to obtain the transfer function parame-
ters coherence, gain, and phase in the
low frequency range (<0.1 Hz). The
inverse fast Fourier transform was then
performed to estimate the impulse and
step responses. The CBFV step response
to a sudden change in blood pressure was
compared with 10 template curves pro-
posed by Tiecks et al16 and the best-ﬁt
curve that corresponded to the ARI. An
ARI value of 9 represents the best
observed cerebral autoregulation.16
Measurements were rejected if
coherence did not reach 0.5 for any fre-
quency <0.25 Hz. Reported baseline
CBFV, blood pressure, RAP, and CrCP
were the averages over the 7-minute
baseline recording.
All data sets were checked for
normalcy of distribution (Sigmastat
2004; Systat Software, Richmond, CA).
Data are reported as mean and standard
deviation or median with the corre-
sponding range, as appropriate. Analyses
were performed with analysis of variance
with Bonferroni’s post-hoc test, analysis
of variance on ranks with Dunn’s post
hoc test (both comparisons vs the con-
trol group), and a second analysis that
used multiple linear regression that
included prepregnancy body mass index
and gestational age at study that was
performed to control for these potential
confounders.
c2 without Yates correction was used
for analysis between groups. The Student
t test or Mann-Whitney Rank Sum test
were used for subgroup analysis. Uni-
variate regression analysis was used to
TABLE 1
Demographic data
Variable
Preeclampsia
(n[ 30)
Chronic
hypertension
(n[ 30)
Gestational
hypertension
(n[ 20)
Control subjects
(n[ 30) P valuea
Maternal age, yb 30  7 29  6 31  5 30  6 .83
Pregestational body
mass index, kg/m2b
29  8 36  9c 31  8 31  5 < .001
Diabetes mellitus, n (%) 6 (20) 6 (20) 2 (10) 0 .061
Type 2 2 (7) 2 (7) 0 —
Gestational 4 (13) 4 (13) 2 (10) —
Twin pregnancy, n (%) 5 (17) 0 3 (15) 2 (7) .11
Nulliparous, n (%) 23 (77)d 11 (37) 12 (60) 17 (57) .020
Estimated gestational
age, wke
At study 354 (241e401) 334 (20 e382)d 371 (276e386) 360 (233e403) .002
At delivery 356 (243e402)d 372 (244e391)d 380 (286e390)d 391 (334e410) < .001
a Analysis of variance on ranks or chi-square; b Data are given as mean  standard deviation; c P < .001 vs control (analysis of variance with Bonferroni test); d P < .05 vs control (analysis of
variance on ranks with Dunn’s test); e Data are given as median (range).
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ajog.org Obstetrics Researchassess the relationship between autor-
egulation parameters and blood pres-
sure. A 2-tailed probability value of< .05
was used to indicate statistical
signiﬁcance.FIGURE 1
Average CBFV step responses of all groups
Error bars represent largest  standard error of the mean.
a.u, arbitrary unit; CBFV, cerebral blood flow velocity; CHTN, chronic hypertension; GHTN, gestational hypertension; PE, preeclampsia.
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A total of 30 patients with preeclampsia
(new onset, 23; SiPE, 7 [conﬁrmed pre-
eclampsia at the time of measurement]),
30 patients with CHTN (with antihy-
pertensive treatment, 16; without anti-
hypertensive treatment, 14), 20 patients
with GHTN, and 30 control subjects
were enrolled. Of the women with
CHTN who had undergone antihyper-
tensive therapy, 12 women used only
labetalol, and 2 women had labetalol
combined with either hydralazine/furo-
semide or nifedipine. The other 2
women received metoprolol for blood
pressure control.
Seven patients (23%) with CHTN (5
women with and 2 women without
medication), 3 patients (10%) in the
control group, and 5 patients (25%) with
GHTN later experienced preeclampsia.
Maternal demographics were similar
for both groups, except for gestational
age at examination and delivery,pregestational body mass index, and
parity (Table 1).
Womenwith preeclampsia/SiPE (ARI,
5.5 1.6) or CHTN (ARI, 5.6 1.7) hadAPRIL 2015 Ameria signiﬁcantly lower ARI than the control
group (ARI, 6.7 0.8); GHTN (ARI, 6.7
 0.8) was not associated with an altered
ARI (Figure 1, Table 2). There was nocan Journal of Obstetrics& Gynecology 513.e3
TABLE 2
Hemodynamic data
Variable
Preeclampsia (n[ 30)/
New preeclampsia
(n[ 23)/Superimposed
preeclampsia (n[ 7)
Chronic hypertension
(n[ 30)/No later
preeclampsia (n[ 23)/
Later preeclampsia (n[ 7)
Gestational hypertension
(n[ 20)/No later
preeclampsia (n[ 15)/
Later preeclampsia
(n[ 5)
Control subjects (n[ 30)/
No later preeclampsia
(n[ 27)/Later
preeclampsia (n[ 3) P valuea
Autoregulation indexb 5.5  1.6c/6.0  1.1/3.9
 2.2d
5.6  1.7c/6.1  1.2/3.9  1.9d 6.7  0.8/6.7  1.0/6.9  0.3 6.7  0.8/6.6  0.8/7.2  0.3 < .001
Mean arterial pressure, mm Hgb 103  13e/101  12/111
 14
94  12e/92  12/100  11 100  11e/98  11/107  6 83  10/82  10/91  10 < .001
End-tidal CO2, mm Hg
b 33  2/33  2/34  2 33  2/33  2/33  3 34  1/34  1/33  1f 33  2/33  2/34  0.3 .40
Mean cerebral blood flow
velocity, cm/secb
86  32e/78  16/113
 55f
69  11/68  11/71  11 68  11/68  12/71  6 68  9/67  9/76  5 < .001
Critical closing pressure, mm Hgg 5 (0e40)/9 (0e40)/1 (0e34) 14 (0e35)/15 (0e35)/7 (0e33) 7 (0e34)h/7 (0e34)/10 (2e14) 16 (0e26)/15 (0e26)/21 (12e23) .012
Resistance area product,
mm Hg  sec  cm1b
1.29  0.37i/1.21  0.33/
1.55  0.41f
1.17  0.36/1.13  0.35/
1.28  0.40
1.39  0.25c/1.37  0.28/
1.42  0.08
1.05  0.22/1.06  0.23/0.96
 0.20
.001
Time study to preeclampsia
diagnosis, dg
15 (4e108) 5 (2e14) 35 (10e78) .12
a Adjusted for body mass index and gestational age at measurement; b Data are given as mean standard deviation; c P< .01 vs control subjects (analysis of variance with Bonferroni test); d P< .01 vs new preeclampsia or no later preeclampsia (t-test or Mann-
Whitney U test); e P  .001 vs control subjects (analysis of variance with Bonferroni test); f P < .05; g Data are given as median (range); h P < .05 (analysis of variance on ranks with Dunn’s test); i P < .05 vs control.
van Veen. Cerebral autoregulation in hypertensive pregnancy. Am J Obstet Gynecol 2015.
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FIGURE 2
Average CBFV step responses of the preeclampsia group
The group was subdivided into superimposed preeclampsia and preeclampsia. Error bars represent
largest  standard error of the mean.
a.u., arbitrary unit; CBFV, cerebral blood flow velocity; PE, preeclampsia; SiPE, superimposed preeclampsia.
van Veen. Cerebral autoregulation in hypertensive pregnancy. Am J Obstet Gynecol 2015.
ajog.org Obstetrics Researchdifference in ARI between women with
CHTN with and without medication
(ARI, 5.4 1.9 vs 5.8 1.4, respectively;
P¼ .55). These outcomes did not change
after adjustment for prepregnancy body
mass index and gestational age at the
time of study.
The ARI of women with SiPE was
signiﬁcantly lower than for those women
with new onset preeclampsia (ARI, 3.9
2.2 vs 6.0  1.1, respectively; P ¼ .002;
Figure 2), but the ARI in new onset
preeclampsia was still decreased when
compared with the control group (ARI,
6.0  1.1 vs 6.7  0.8, respectively; P ¼
.007). RAP was signiﬁcantly higher in
preeclampsia and GHTN than in the
control subjects and even higher in the
patients with SiPE. CrCP was lower in
women with GHTN than in control
subjects; however, although there was a
trend to a lower CrCP in preeclampsia,
this difference did not reach signiﬁcance.
ARI, RAP, and CrCP were not asso-
ciated signiﬁcantly with mean arterial
blood pressure in women with pre-
eclampsia. However, in both CHTN and
control pregnant women, blood pressurewas associated positively with RAP (P <
.0001 and P ¼ .014, respectively).
Women with GHTN demonstrated a
mean arterial blood pressure positive
associationwith CrCP and ARI (P¼.026
and P ¼ .037, respectively).
In subgroup analysis of women who
did or did not experience preeclampsia
(Table 2), the ARIwas signiﬁcantly lower
in women with CHTN who subse-
quently experienced SiPE vs those that
did not. This was not seen in the GHTN
group or control subjects. The time be-
tween the measurements and the devel-
opment of preeclampsia varied widely
but was not different among the 3 groups
(Table 2).
COMMENT
In this study, we examined the auto-
regulation functionality in different
hypertensive states of pregnancy and
compared themwith those that were seen
in pregnant normotensive control sub-
jects. Our ﬁndings indicate that cerebral
autoregulation is impaired in pregnant
women with CHTN and preeclampsia
and even more so in patients with SiPE.APRIL 2015 AmeriCerebral autoregulation is, however, in-
dependent from the actual blood pressure
values. Furthermore, the functionality of
autoregulation is impaired in pregnant
women with CHTN, who subsequently
experienced SiPE when compared with
women who did not experience SiPE.
These results may explain the reason that
womenwith CHTNor preeclampsia have
an increased risk of the development of
cerebral complications or stroke during
pregnancy, even without sudden or
excessive elevation in blood pressure.11-13
Previous studies also have shown
abnormal cerebral hemodynamics in
preeclampsia, SiPE, and CHTN6,21-23
and have interpreted the ﬁnding of
increased cerebral perfusion pressure or
CBFV as impaired autoregulation.
However, none of these studies
measured CBFV and blood pressure
simultaneously and therefore could not
assess the dynamic cerebral autor-
egulation. More recently, our group
demonstrated decreased ARI in women
with preeclampsia when compared with
normotensive control subjects,5 with the
largest degree of impairment in women
with SiPE who required 2 antihyper-
tensive drugs to control their blood
pressure. In this study, we also found a
signiﬁcant difference between SiPE and
new onset preeclampsia. Indeed, the ARI
of patients with new onset preeclampsia
was not much different from the ARI of
patients with CHTN (ARI, 5.9  1.3 vs
5.6  1.7, respectively; P ¼ .48). But in
both groups, the large range in ARI in-
dicates nonhomogeneity in disease
severity and possibly pathophysiologic
condition. In addition, women with
CHTN who subsequently experienced
SiPE had a signiﬁcantly lower ARI than
those who did not progress to this dis-
ease; the ARIs in the GHTN and control
groups were similar for those who did
and did not progress to preeclampsia.
The spectrum of conditions (which
ranged from SiPE, preeclampsia, and
CHTN to GHTN and control subjects),
along with their associated spectrum in
ARI, might reﬂect a range of endothelial
impairment. Scientiﬁc evidence sug-
gests that altered expression of angio-
genic factors produces systemic
endothelial dysfunction and plays ancan Journal of Obstetrics& Gynecology 513.e5
Research Obstetrics ajog.orgimportant role in the pathogenesis of
preeclampsia.14 The extent of these de-
viations depends on the type of hyper-
tensive disorder, which is more
pronounced in preeclampsia than in
women with CHTN and GHTN when
compared with control subjects.24-26
Another study found an altered angio-
genic balance in preeclampsia, but not
in GHTN.27 These results are in agree-
ment with our study. We also found that
the ARI was lowest in the preeclampsia
group; the ARI in women with GHTN
was similar to the control group. The
proteinuria that is seen in preeclampsia
is caused by renal endothelial dysfunc-
tion and is also related to this angio-
genic inbalance.14
The increase in RAP that was seen in
women with GHTN and preeclampsia is
in accordance with a previous study,
which suggests that RAP might reﬂect
myogenic activity.28 Interestingly, CrCP,
which is more indicative of metabolic
control,28 appears to be decreased in
both preeclampsia and GHTN, which
counteracts the effect of RAP and sug-
gests an abnormal neurovascular
coupling, which was also seen in former
(pre)eclamptic women.29 Further work
is required to establish the interpretation
and signiﬁcance of this difference.
Women with CHTN who subse-
quently did experience SiPE had a
signiﬁcantly decreased ARI. Their ARI
was comparable with patients who
already had SiPE. This can be explained
in 2 possible ways: ﬁrst, it is possible that
the changes in cerebral autoregulation
occur before clinical symptoms of SiPE
appear, which reﬂects early manifesta-
tion of disease or the underlying patho-
physiologic condition. This possibility is
further supported by the ﬁnding that
CHTN outside of pregnancy does not
appear to alter cerebral autoregulation,
even in sustained untreated middle-aged
and older people.30-32 Furthermore,
previous research has demonstrated that
decreased maternal middle cerebral ar-
tery resistance in the second trimester
was predictive of subsequent pre-
eclampsia in low-risk pregnant women
who can be expected to have no endo-
thelial dysfunction at the time of the
TCD examination.33 These ﬁndings,513.e6 American Journal of Obstetrics& Gynecolcoupled with evidence that angiogenic
factors have been detected in maternal
serum 5-10 weeks before the onset of
preeclampsia, suggest that ARI may
indeed be impaired in these cases well
before the clinical manifestation of dis-
ease.14,24,27 If this is in fact true, the ARI
could have the potential of being used as
a screening tool.
Second, the reduced ARI is an indi-
cation of baseline endothelial dysfunc-
tion, whichmakes pregnant womenwith
CHTN more susceptible for the devel-
opment of SiPE. This is supported by the
fact that women with CHTN or diabetes
mellitus experience preeclampsia at a
lower level of angiogenic disturbance25
and would also explain the reason that
the ARI in women with GHTN and
control subjects was normal. In CHTN,
endothelial function is already impaired,
and the angiogenic imbalance causes a
second hit and SiPE. This theory is in
agreement with Noori et al,27 who found
impaired endothelial function in the
brachial artery before angiogenic factors
were altered.
One of the strengths of this study is
the inclusion of patients with multiple
hypertensive disorders of pregnancy and
a pregnant control group, who were all
studied in an identical setting. Further,
none of the women received magnesium
sulfate or had recent changes in antihy-
pertensive therapy at time of the
measurement.
This study also has some limitations
that merit discussion. A limitation of the
use of TCD is that only the CBFV can be
obtained and therefore relies on the
assumption that changes in CBFV are
directly proportional to changes in CBF.
The data only represent a 7-minute
period. Although the reliability of the
method has been proved in a longitudi-
nal fashion in nonpregnant subjects, this
might not hold true for preeclampsia,
during which blood pressures can be
very labile. The study has a small sample
size, predominantly in the SiPE, and
GHTN groups, and in the comparison of
those who did vs did not experience
preeclampsia later during their preg-
nancy, which precluded any detailed
subgroup analysis on severity of pre-
eclampsia, laboratory abnormalities, orogy APRIL 2015neurologic symptoms. The incidence
and severity of adverse events in CHTN
is related to the duration of the disease
and the severity and control of the hy-
pertension,7 but we do not have infor-
mation on this from our patients.
Finally, the women with CHTN had a
signiﬁcant higher pregestational body
mass index and were studied at a
younger gestational age; however, con-
trolling for this possible confounder in a
multiple regression analysis did not
change the results.
In conclusion, our ﬁndings suggest
the presence of impaired dynamic cere-
bral autoregulation in patients with
preeclampsia, particularly in those with
SiPE, when compared with their GHTN
or normotensive counterparts. The
autoregulation is impaired in patients
with CHTN who subsequently experi-
ence SiPE, but not in normotensive
pregnant women or women with GHTN
who subsequently experience pre-
eclampsia. Whether this disparity is due
to preexistent differences or early
affected cerebral circulation in pregnant
women with CHTN remains to be
determined. -REFERENCES
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